Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

Skip to main content
search

Under the theme ‘Tobacco harm reduction, here for good’, this year’s Global Forum on Nicotine (GFN) held in Warsaw, underscored the need for greater urgency and ambition to end smoking by implementing policy grounded in both science and human rights.

Hundreds of consumer advocates returned to Warsaw, Poland for the first time in two years for an in-person forum, with the event having over 50 international experts on nicotine and tobacco. The leading topic of the ninth nicotine congress was limiting health harms associated with smoking.

Topics focused on reducing health harm to smokers and health policy based on legal regulations for alternative nicotine products, such as e-cigarettes. In addition to the panels, the conference program included speeches by 3 keynote speakers and interviews at the GFN  TV studio.

Studies and statistics were presented from dozens of countries, which show a reduction in deaths and hospitalizations from smoking-related diseases, after the entry of alternative tobacco products into these countries, such as e-cigarettes, non-combustible products, snus etc.

Professor Karl Fagerström from Sweden, made a brief presentation of the evolution of sales of cigarettes, snus and nicotine pouches in Sweden from 1916 until today. He noted that the entry of snus, but also nicotine pouches, in 1973 and 2016 respectively, coincided with a significant decline of cigarette sales in Sweden. 

He then presented data from the Eurobarometer (February 2021) showing that Sweden is a unique example in Europe, where smokers have fallen below 5% of the total population, and deaths and hospitalizations due to diseases related to smoking are much lower than the European average. He said snus is the first and only tobacco product to date that has been approved by the FDA as a reduced risk product for lung and oral cancer.

This year’s Michael Russell Award recipient at the ninth edition of the Global Forum on Nicotine was Professor Brad Rodu, a professor of Medicine at the University of Louisville (UofL) in Kentucky.

A new study by Dr. Lars M. Ramström, a renowned tobacco dependence researcher, was also launched at the GFN. The research findings show that switching from smoking to Swedish-style snus, a safer nicotine product, is a more effective strategy to reduce the harms caused by tobacco. 

What Does this Mean for Africa?

Policymakers in Africa can learn from the new research which shows there is no clear association between the implementation of the World Health Organization’s (WHO) tobacco control measures and low levels of tobacco-related mortality.

Africa is falling behind the rest of the world in the battle to save the lives of millions of smokers. According to the World Health Organization, more than 80% of the world’s current smokers live in low- and middle- income countries. In Sub-Saharan Africa, the increase in tobacco smoking is facilitated by the fast-growing population and an increase in purchasing power of the consumers. 

Stakeholders must learn from the countries like Sweden, the UK and New Zealand where alternative nicotine products are being used to slash smoking rates. Sweden is about to be the first country in the world to become smoke-free thanks to oral nicotine products. For Africa, such an achievement is a pipe dream due to our governments’ refusal to embrace safer alternatives.

Dr Karl Fagerström’s research demonstrates that tobacco-free oral nicotine products are likely to have the best potential for harm reduction among smokers who switch. 

The World Health Organization continues to mistakenly advocate for prohibitions of low-risk alternatives to smoking and applauds those countries that ban these products. Policymakers in Africa must consider the likely cost to human life of such bans.

Author: Joseph Magero of Campaign for Safer Alternatives.
THR IN AFRICA

Related Posts

Harm Reduction AfricaNicotine PouchesTHR in AfricaVapingLetter to the World Health Organization (WHO)
27 October 2021

Letter to the World Health Organization (WHO)

Letter to the World Health Organization (WHO) and delegates of the Ninth Conference of Parties (COP9) regarding the Framework Convention…
Oral NicotineVapingPublic Health implications of vaping in Germany
21 November 2021

Public Health implications of vaping in Germany

Prof Levy’s SAVM model predicts 4.7 million life-years saved, and 300,000 deaths avoided by 2060 In Germany’s population of 84…
Vaping Health Implications USADrug Harm ReductionVapingPublic Health implications of vaping in the United States of America
26 November 2021

Public Health implications of vaping in the United States of America

Public health implications of vaping in USA: Prof Levy’s SAVM model predicts 38.9 million life-years saved, and 1.8 million deaths…
Alcohol Harm Reduction

More about

Alcohol Harm Reduction

Drug Harm Reduction

More about

Drug Harm Reduction